Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FTT PET in Metastatic Breast Cancer
NCT06502691Phase 2Recruiting
- Sponsor
- University of Washington
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]FluorThanatrace in breast cancer, sponsored by University of Washington. Started Feb 2026; status: recruiting.
02
Drugs
[18F]FluorThanatrace
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06502691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06502691.